Walgreens Boots Alliance, Inc. (NASDAQ:WBA) was downgraded by investment analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a research note issued on Saturday.

Several other research firms have also recently weighed in on WBA. Guggenheim restated a “buy” rating and set a $100.00 price target on shares of Walgreens Boots Alliance in a report on Thursday, April 6th. Jefferies Group LLC restated a “buy” rating and set a $95.00 price target on shares of Walgreens Boots Alliance in a report on Thursday, April 6th. Zacks Investment Research upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Wednesday, March 29th. Robert W. Baird restated an “outperform” rating and set a $96.00 price target on shares of Walgreens Boots Alliance in a report on Monday, March 27th. Finally, Barclays PLC set a $79.00 price target on Walgreens Boots Alliance and gave the company a “hold” rating in a report on Saturday, April 1st. Three research analysts have rated the stock with a sell rating, three have assigned a hold rating and eleven have issued a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $90.62.

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Walgreens Boots Alliance (NASDAQ WBA) traded down 0.04% during mid-day trading on Friday, reaching $76.34. The company had a trading volume of 9,741,171 shares. The firm has a 50-day moving average of $82.60 and a 200 day moving average of $83.69. Walgreens Boots Alliance has a 1-year low of $75.18 and a 1-year high of $88.00. The company has a market capitalization of $82.52 billion, a PE ratio of 19.62 and a beta of 1.20.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Wednesday, April 5th. The pharmacy operator reported $1.36 earnings per share for the quarter, meeting the consensus estimate of $1.36. The business had revenue of $29.45 billion during the quarter, compared to analysts’ expectations of $30.17 billion. Walgreens Boots Alliance had a return on equity of 16.86% and a net margin of 3.66%. The firm’s revenue for the quarter was down 2.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.31 EPS. On average, analysts predict that Walgreens Boots Alliance will post $4.97 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Monday, June 12th. Investors of record on Thursday, May 18th were paid a dividend of $0.375 per share. This represents a $1.50 dividend on an annualized basis and a dividend yield of 1.96%. The ex-dividend date was Tuesday, May 16th. Walgreens Boots Alliance’s dividend payout ratio is currently 38.36%.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by American Banking News and is owned by of American Banking News. If you are viewing this piece on another website, it was stolen and republished in violation of United States and international trademark and copyright law. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2017/06/24/walgreens-boots-alliance-inc-wba-rating-lowered-to-strong-sell-at-bidaskclub.html.

In related news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction that occurred on Wednesday, May 3rd. The stock was sold at an average price of $85.89, for a total transaction of $234,995.04. Following the completion of the sale, the director now directly owns 21,887 shares of the company’s stock, valued at approximately $1,879,874.43. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 13.50% of the stock is currently owned by company insiders.

Large investors have recently modified their holdings of the company. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA raised its stake in shares of Walgreens Boots Alliance by 1.4% in the third quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 180,254 shares of the pharmacy operator’s stock worth $14,532,000 after buying an additional 2,465 shares in the last quarter. Gluskin Sheff & Assoc Inc. raised its stake in shares of Walgreens Boots Alliance by 11.9% in the second quarter. Gluskin Sheff & Assoc Inc. now owns 318,140 shares of the pharmacy operator’s stock worth $26,492,000 after buying an additional 33,707 shares in the last quarter. Tompkins Financial raised its stake in shares of Walgreens Boots Alliance by 1.6% in the fourth quarter. Tompkins Financial now owns 41,117 shares of the pharmacy operator’s stock worth $3,501,000 after buying an additional 645 shares in the last quarter. Gibraltar Capital Management raised its stake in shares of Walgreens Boots Alliance by 7.5% in the fourth quarter. Gibraltar Capital Management now owns 43,190 shares of the pharmacy operator’s stock worth $3,678,000 after buying an additional 3,015 shares in the last quarter. Finally, Cim LLC raised its stake in shares of Walgreens Boots Alliance by 1.7% in the third quarter. Cim LLC now owns 104,355 shares of the pharmacy operator’s stock worth $8,413,000 after buying an additional 1,702 shares in the last quarter. 61.32% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.